Simon Kiddle has an MA in Chemistry from the University of Oxford and joined Mewburn Ellis in 1991. His practice covers the fields of biological chemistry, pharmaceuticals and biotechnology. He has extensive experience in assisting clients with strategic portfolio planning and due diligence work for companies and investors. Simon's practice is mainly divided between advising UK and European start-up companies and universities, prosecuting patent applications for US biotechnology companies and handling European oppositions and appeals. His clients include companies and institutions active in the areas of glycobiology, protein engineering, sugar chemistry, microfluid devices and microarray technology.